Alzamend Neuro, Inc. ALZN
Set alert
1.21 USD -0.01 -0.82%
At close · Oct 30
1.21 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
1.21 Day range 1.33
0.858 52-week range 2.61
- YTD
- -33.52%
- 1 year
- -53.64%
- Open
- 1.29
- Prev close
- 1.22
- Mkt cap
- 5.84M
- Vol
- 25.03K
- Avg vol
- 79.67K
- EPS
- -2.30
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.21
- High
- 1.33
- Forward P/E
- -0.26
- Beta
- -0.04
- Short ratio
- 1.03
- Inst. own
- 0.94%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Sep 11, 2024
- 50-d avg
- 1.42
- 200-d avg
- 4.08
- 1y target
- 32.00
5D chart
Signals (16)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 3:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:20 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:50 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:35 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:10 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:40 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:20 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:30 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:50 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:10 PM | 5 days ago |
Financial health
Altman Z-Score
-12.99 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -0.4×
FY 2017 5y median -0.5× FY 2026
P/S 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 5.2×
FY 2017 5y median 5.2× FY 2026
P/FCF -0.5×
FY 2017 5y median -0.6× FY 2026
EV/EBITDA -0.4×
FY 2017 5y median -0.5× FY 2026
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -212.1%
FY 2017 5y median -175.4% FY 2026
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -1196.4%
FY 2017 5y median -113.8% FY 2026
ROIC -1195.7%
FY 2017 5y median -113.3% FY 2026
ROA -421.9%
FY 2017 5y median -251.5% FY 2026
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2026
Operating Income -95.0%
FY 2017 FY 2026
EPS (diluted) 76.8%
FY 2017 FY 2026
Free Cash Flow -17.5%
FY 2017 FY 2026
Financial Health
Current Ratio 1.3×
FY 2017 5y median 2.0× FY 2026
Quick Ratio 1.3×
FY 2017 5y median 2.0× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.1×
FY 2017 5y median 0.3× FY 2026
Interest Coverage 1324×
FY 2017 5y median -265× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-04-30